NEW YORK (GenomeWeb News) – The National Institute of Allergy and Infectious Disease will provide up to $26 million to cooperative research partnerships that address biodefense and emerging infectious disease issues.
 
The program aims to develop diagnostics, vaccines, therapeutics, and immunotherapeutics specific to Category A, B, and C pathogens or toxins.
 
The $26 million will fund between 15 and 20 awards, and the size and duration of these awards will vary.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.